bf/NASDAQ:OCUL_icon.jpeg

NASDAQ:OCUL

Ocular Therapeutix

  • Stock

8.53

+2.77%

−3.97

USD last updated 14/08 01:46:41

Last Close

12.50

13/08 20:07

Market Cap

1.11B

Beta: 1.30

Volume Today

1.43M

Avg: 1.63M

PE Ratio

−5.67

PFCF: −7.52

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a de...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.6-0.5-0.4-0.3-0.2-0.12017-08-082019-08-072021-08-092023-08-072024-08-07

    Revenue (Estimate*)

    5M10M15M20M2017-08-082019-08-072021-08-092023-08-072024-08-07

    *Estimate based on analyst consensus